권호기사보기
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
결과 내 검색
동의어 포함
Title page 1
Contents 6
Introduction 9
1. Background 12
1.1. Why develop new technologies to remediate waste? 12
1.2. Considerations for containment versus environmental release 13
1.3. Role of federal agencies 15
2. Benefits, Limitations, Potential Risks, and Status of Engineered Microbes for Cleanup 18
2.1. Engineered microbes may offer benefits over existing remediation and waste treatment 18
2.2. Limitations and potential risks may restrict use or be difficult to address 19
2.2.1. Technical limitations 19
2.2.2. Potential risks 19
2.3. Engineered microbes for waste cleanup are not commercially available 20
3. Demonstrating Safety and Effectiveness 24
3.1. Gaps in knowledge 24
3.2. Insufficient testing infrastructure and standards 25
3.3. Regulatory burdens 29
4. Developing a Market 32
4.1. Unclear regulatory responsibilities and long review times 32
4.2. Lack of manufacturing facilities and demonstrations at scale 34
4.3. Public skepticism and a lack of community engagement 35
5. Alternatives to Policies Advancing Engineered Microbes for Cleanup 38
5.1. Contained approaches may address some, but not all concerns about testing for environmental release 38
5.2. The private market may address some, but not all challenges 38
5.3. Alternative policy options 39
6. Agency and Expert Comments 40
Appendix I. Objectives, Scope, and Methodology 41
Appendix II. Expert Participation 44
Appendix III. GAO Contacts and Staff Acknowledgments 46
Figure 1. Example areas where engineered microbes could be deployed for waste cleanup 10
Figure 2. Engineered microbes may be designed for contained use or environmental release 14
Figure 3. History of the coordinated framework for the regulation of biotechnology 17
Figure 4. Scaling up testing of engineered microbes for bioremediation 27
*표시는 필수 입력사항입니다.
| 전화번호 |
|---|
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
| 번호 | 발행일자 | 권호명 | 제본정보 | 자료실 | 원문 | 신청 페이지 |
|---|
도서위치안내: / 서가번호:
우편복사 목록담기를 완료하였습니다.
*표시는 필수 입력사항입니다.
저장 되었습니다.